CONTACT

BioRN Network e.V.

Im Neuenheimer Feld 582

D-69120 Heidelberg

Contact us >>

INFORMATION

BioRN is the science and industry cluster of the Rhine-Main-Neckar region around Heidelberg, one of Germany’s strongest biotech hubs. It is a non-profit network fostering health innovations, supporting a rich translational ecosystem and promoting, representing and connecting the regional innovation stakeholders.

  • LinkedIn Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon

"We make Life Science matter...

...and Innovation happen!"

cl_label_silber.png

© Copyright - BioRN Network e.V. -  Imprint & Legal Notice - Data Privacy Policy

Executive Board

Dr. Gitte Neubauer (Chair)
CEO of Cellzome GmbH - a GSK company, Heidelberg
Prof. Dr. Michael Boutros (Deputy Chair)
 
Head of Functional and Structural Genomics Program at the German Cancer Research Center (DKFZ), Heidelberg
Dr. André H.R. Domin
Managing Director of the Technologiepark Heidelberg GmbH, Heidelberg
Dr. Stefan Herr
CEO of EMBL Ventures GmbH, Heidelberg
Prof. Dr. Magnus von Knebel Doeberitz
Director, Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg
Dr. Volker Stadler
CEO of PEPperPRINT GmbH, Heidelberg
Dr. Axel Wiest
Chief Operating Officer R&D, Merck KGaA, Darmstadt
Dr. André H.R. Domin
Managing Director of the Technologiepark Heidelberg GmbH, Heidelberg
Dr. Stefan Herr
CEO of EMBL Ventures GmbH, Heidelberg
Prof. Dr. Magnus von Knebel Doeberitz
Director, Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg
Dr. Volker Stadler
CEO of PEPperPRINT GmbH, Heidelberg
Dr. Axel Wiest
Chief Operating Officer R&D, Merck KGaA, Darmstadt

Strategic Advisory Board

The strategic board is an advisory body, endoursed with the task of advising the executive board particularly on strategic issues or reviewing executive board decisions.
Dr. Siegfried Bialojan, Executive Director, Head Life Science Center, Ernst & Young GmbH, Mannheim
Dr. Elmar Bourdon, Manager of Medical Technology Cluster, City of Mannheim
Prof. Dr. Bernd Bukau, Director of Zentrum für Molekulare Biologie Heidelberg (ZMBH)
Dr. Adrian J. Carter, Corporate Vice President of Discovery Research Coordination, Boehringer Ingelheim International GmbH, Ingelheim am Rhein
Dr. Jürgen Gamer, VP Business Development Apogenix AG, Heidelberg
Dr. Jan Gradel, Director Business Development Sino German Hi Tech Park Holding GmbH, Heidelberg
Martin Haag, Site Manager, Roche Diagnostics GmbH, Mannheim
Thomas Hegendoerfer, New Ventures Lead in Germany for Johnson & Johnson Innovation, Neuss
Dr. Martin Raditsch, CEO INNOVECTIS GmbH, Frankfurt am Main
Dr. Joerg Rauch, Managing Director, technology transfer heidelberg GmbH
Dr. Stefan Simianer, Vice President International Development & General Manager R&D, AbbVie Deutschland GmbH & Co. KG, Ludwishafen
Dr. Chistian Tidona (Chair), Managing Director BioMed X GmbH, Heidelberg
Prof. Dr. Heike Andrea Wieland, Director External Ecosystem R&D, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main

Scientific Advisory Board

The Scientific Advisory Board is an advisory body entrusted with the task of advising the executive board particularly in the selection and evaluation of project ideas and projects
Dr. Christof Antz, Velabs Therapeuticals GmbH, Heidelberg
Dr. Juergen Bauer, Deputy Managing Director, Head of Business Development, EMBLEM Technology Transfer GmbH, Heidelberg
PD Dr. Gerard Drewes, Head of Science, Cellzome GmbH – a GSK company, Heidelberg
Prof. Dr. Mathias Hafner (Chair), Director of the Institute for Molecular and Cell Biology, Mannheim University of Applied Sciences
Prof. Dr. Alfred Hahn, Head of Discovery, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen
Prof. Dr. Klaus Heeg, Deputy Managing Director of the Center of Infection Diseases, Microbiologies and Hygiene, University Hospital Heidelberg
Dr. Thomas Höger, CEO and co-founder, Apogenix GmbH, Heidelberg
Dr. Thomas Pultar, CEO, BIOMEVA GmbH, Heidelberg
Dr. Friedrich Rippmann, Director, Global Computational Chemistry Merck KGaA, Darmstadt
Prof. Dr. Andreas Trumpp, Managing Director of HI-STEM, Professor and Head of the Division of Stem Cell and Cancer at the DKFZ Heidelberg